SEC Form 4 · accession 0001209191-18-005204
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
Jan 22, 2018
Accepted (ET)
Jan 24, 2018 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2018 | M | 2,427 | $86.52 | A | 19,061 | D | |
| Common Stock | Jan 22, 2018 | S | 2,427 | $161.52 | D | 16,634 | D | |
| Common Stock | Jan 23, 2018 | M | 1,289 | $91.05 | A | 17,923 | D | |
| Common Stock | Jan 23, 2018 | M | 1,719 | $90.29 | A | 19,642 | D | |
| Common Stock | Jan 23, 2018 | S | 3,008 | $166.05 | D | 16,634 | D | |
| Common Stock | holding | — | — | — | 169 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $86.52 | Jan 22, 2018 | M | 2,427 | D | — | Feb 2, 2027 | Common Stock | 2,427 | 10,517 | D |
| Stock Option (Right to Buy)F3 | $91.05 | Jan 23, 2018 | M | 1,289 | D | — | Feb 1, 2026 | Common Stock | 1,289 | 11,602 | D |
| Stock Option (Right to Buy)F4 | $90.29 | Jan 23, 2018 | M | 1,719 | D | — | Jul 11, 2026 | Common Stock | 1,719 | 8,594 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
- F2The option vests in 16 quarterly installments from 2/3/2017.
- F3The option vests in 16 quarterly installments from 2/2/2016.
- F4The option vests in 16 quarterly installments from 7/12/2016.